Problem

A client had an asset in clinical development that showed activity against multiple tumor types. To guide investment efforts, they needed to assess and prioritize tumor types based on commercial factors.

Solution

• Caravel researched and analyzed several therapeutic areas to assess current and future unmet needs, market size per potential indication, and competition per potential indication.
• Caravel prioritized tumor types for development efforts, based on competitive entrenchment, estimated clinical profile of company asset against current and future competitors, and access/reimbursement environment by tumor type.